BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 12, 2006
View Archived Issues
Cimetidine's potential for cancer treatment reviewed
Read More
ProEthic plans pain relief product launches for 2008
Read More
1-TDC inhibits bacteria and enzymes associated with inflammatory conditions
Read More
Chelsea Therapeutics and Active Biotech sign codevelopment agreement
Read More
Maxygen achieves milestone in Roche factor VIIa collaboration
Read More
ThermoDox development advances on several fronts
Read More
CSA-13 demonstrates efficacy in eradicating a MRSA biofilm
Read More
Nonhuman primate data on PPI-2458 made available
Read More
MyVax idiotype immunotherapy studied in phase I/II study for CLL
Read More
Tranzyme completes phase I study of ghrelin receptor agonist TZP-101
Read More
Prana plans phase IIa study of PBT-2 in Alzheimer's disease patients
Read More
Fast track designation for Shigamabs dual antibody product
Read More
Sirna Therapeutics licenses microRNA technology from UMMS
Read More
ISIS-5320 shows potential as anti-HIV topical microbicide
Read More
Uvidem appears safe in phase II melanoma trial
Read More
Collidem induces immune responses in patients with metastatic colorectal cancer
Read More
VP-025 reduces retinal inflammation in experimental diabetic retinopathy
Read More
German report questions therapeutic benefit of Exubera
Read More
Avantogen and Hawaii Biotech combine vaccine businesses
Read More
Genentech extends Curis Hedgehog funding
Read More
Phase IIb trial studies IPL-512602 in moderate to severe asthma
Read More
Second phase III trial begins for pancreatic enzyme product EUR-1008
Read More
Kaken licenses antifungal compound KP-103 to Dow
Read More
Preclinical and clinical update on NeuGene antisense compound for HCV
Read More
Japanese launch of Femara
Read More
Recent GSK and Boehringer Ingelheim patents report novel agents for HIV infection
Read More
Recent patents impart new therapeutic agents for cancer
Read More
FDA approval for smoking cessation therapy Chantix
Read More
Natural products show potential to prevent skin photoaging
Read More
Novel dual PPARgamma and delta agonist shows antiatherosclerotic potential in vitro
Read More
Schering, Berlex develop compounds that inhibit T-cell but not LPS-mediated TNF-alpha production
Read More